3 Stocks Estimated To Be Trading At Discounts Ranging From 25.7% To 46.4%

Over the last 7 days, the United States market has remained flat, yet it has risen by 15% over the past year with expectations of earnings growing by 18% annually in the coming years. In such a climate, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on companies trading at discounts relative to their intrinsic value.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Zions Bancorporation National Association (ZION)	$62.49	$123.11	49.2%
Pegasystems (PEGA)	$35.65	$69.63	48.8%
M&T Bank (MTB)	$217.49	$422.24	48.5%
KeyCorp (KEY)	$19.97	$39.68	49.7%
Insteel Industries (IIIN)	$29.50	$57.36	48.6%
Gilat Satellite Networks (GILT)	$8.94	$17.27	48.2%
EOG Resources (EOG)	$148.16	$296.27	50%
Artisan Partners Asset Management (APAM)	$33.46	$65.03	48.5%
Amkor Technology (AMKR)	$49.12	$96.22	48.9%
Addus HomeCare (ADUS)	$114.33	$226.18	49.5%

Click here to see the full list of 105 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Netflix (NFLX)

Overview: Netflix, Inc. provides entertainment services worldwide and has a market cap of approximately $292.72 billion.

Operations: The company generates revenue primarily from its streaming entertainment service, amounting to $48.37 billion.

Estimated Discount To Fair Value: 25.7%

Netflix is trading at a significant discount to its estimated future cash flow value, suggesting potential undervaluation. Despite slower projected earnings and revenue growth compared to the broader US market, Netflix's return on equity is forecasted to be very high in three years. However, recent insider selling could be a concern. The company’s strategic moves, such as expanding NFL content distribution through EverPass Media and enhancing content acquisition capabilities with new executive appointments, may bolster future cash flows.

• Upon reviewing our latest growth report, Netflix's projected financial performance appears quite optimistic.
• Delve into the full analysis health report here for a deeper understanding of Netflix.

Bank of America (BAC)

Overview: Bank of America Corporation, with a market cap of approximately $379.85 billion, offers a wide range of financial products and services to individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments globally through its subsidiaries.

Operations: The company's revenue segments include Global Banking at $24.04 billion, Global Markets at $26.62 billion, Consumer Banking at $40.39 billion, and Global Wealth & Investment Management (GWIM) at $26.50 billion.

Estimated Discount To Fair Value: 37.3%

Bank of America is trading at US$54.32, significantly below its estimated future cash flow value of US$86.67, indicating potential undervaluation. Although earnings and revenue growth are projected to lag behind the broader US market, the stock's current price suggests it could offer value based on cash flows. Recent executive changes and product innovations like AskGPS Intelligence Hub may enhance operational efficiency and client engagement, supporting future financial performance despite modest growth forecasts.

• Our growth report here indicates Bank of America may be poised for an improving outlook.
• Click to explore a detailed breakdown of our findings in Bank of America's balance sheet health report.

Boston Scientific (BSX)

Overview: Boston Scientific Corporation develops, manufactures, and markets medical devices for various interventional medical specialties worldwide, with a market cap of approximately $61.93 billion.

Operations: The company's revenue segments consist of MedSurg, generating $7.05 billion, and Cardiovascular (including Rhythm), contributing $13.95 billion.

Estimated Discount To Fair Value: 46.4%

Boston Scientific trades at US$42.73, significantly below its estimated future cash flow value of US$79.7, suggesting potential undervaluation based on cash flows. Despite slower projected revenue and earnings growth compared to the broader market, recent strategic restructuring into three segments could enhance operational efficiency and investment allocation. However, ongoing product recalls may pose risks to financial performance and investor confidence in the short term.

• Our expertly prepared growth report on Boston Scientific implies its future financial outlook may be stronger than recent results.
• Unlock comprehensive insights into our analysis of Boston Scientific stock in this financial health report.

Where To Now?

• Gain an insight into the universe of 105 Undervalued US Stocks Based On Cash Flows by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com